Development of experimental tumors formed by mouse and human embryonic stem and teratocarcinoma cells after subcutaneous and intraperitoneal transplantations into immunodeficient and immunocompetent mice

Cell Transplantation

Volumn 22, Issue 10, 2013, Pages 1901-1914

  Gordeeva, O F ^a   Nikonova, T M ^a  

^a KOL TSOV INSTITUTE OF DEVELOPMENTAL BIOLOGY   (Russian Federation)

Author keywords

Nude mice; Oct4; Pluripotent stem cells; Teratocarcinoma; Teratoma; Transplantation

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER TRANSPLANTATION; CARCINOGENICITY; CELL COUNT; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYONAL CARCINOMA STEM CELL; EMBRYONIC STEM CELL; EXPERIMENTAL NEOPLASM; GERM LAYER; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; TERATOMA;

ANIMALS; EMBRYONIC STEM CELLS; HUMANS; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; KARYOTYPING; MICE; MICE, INBRED C57BL; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; TERATOMA;

EID: 84884698167     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X657837     Document Type: Article

References (53)

1. Blum, B.; Benvenisty, N. The tumorigenicity of diploid and aneuploid human pluripotent stem cells. Cell Cycle 8:3822-3830; 2009.
2. Bottai, D.; Cigognini, D.; Madaschi, L.; Adami, R.; Nicora, E.; Menarini, M.; Di Giulio, A. M.; Gorio, A. Embryonic stem cells promote motor recovery and affect inflammatory cell infiltration in spinal cord injured mice. Exp. Neurol. 223:452-463; 2010.
3. Boyd, A. S.; Wu, D. C.; Higashi, Y.; Wood, K. J. A comparison of protocols used to generate insulin-producing cell clusters from mouse embryonic stem cells. Stem Cells 26:1128-1137; 2008.
4. Brederlau, A.; Correia, A. S.; Anisimov, S. V.; Elmi, M.; Paul, G.; Roybon, L.; Morizane, A.; Bergquist, F.; Riebe, I.; Nannmark, U.; Carta, M.; Hanse, E.; Takahashi, J.; Sasai, Y.; Funa, K.; Brundin, P.; Eriksson, P. S.; Li, J. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: Effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells 24:1433-1440; 2006.
5. Byrne, J. A.; Pedersen, D. A.; Clepper, L. L.; Nelson, M.; Sanger, W. G.; Gokhale, S.; Wolf, D. P.; Mitalipov, S. M. Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature 450:497-502; 2007.
6. Caisander, G.; Park, H.; Frej, K.; Lindqvist, J.; Bergh, C.; Lundin, K.; Hanson, C. Chromosomal integrity maintained in five human embryonic stem cell lines after prolonged in vitro culture. Chromosome Res. 14:131-137; 2006.
7. Cao, F.; van der Bogt, K. E. A.; Sadrzadeh, A.; Xie, X.; Sheikh, A. Y.; Wang, H.; Connolly, A. J.; Robbins, R. C.; Wu, J. C. Spatial and temporal kinetics of teratoma formation from murine embryonic stem cell transplantation. Stem Cells Dev. 16:883-891; 2007.
8. Caspi, O.; Huber, I.; Kehat, I.; Habib, M.; Arbel, G.; Gepstein, A.; Yankelson, L.; Aronson, D.; Beyar, R.; Gepstein, L. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J. Am. Coll. Cardiol. 50:1884-1893; 2007.
9. Cooke, M. J.; Stojkovic, M.; Przyborski, S. A. Growth of teratomas derived from human pluripotent stem cells is influenced by the graft site. Stem Cells Dev. 15:254-259; 2006.
10. Dressel, R. Effects of histocompatibility and host immune responses on the tumorigenicity of pluripotent stem cells. Semin. Immunopathol. 33:573-591; 2011.
11. Dressel, R.; Schindehütte, J.; Kuhlmann, T.; Elsner, L.; Novota, P.; Baier, P. C.; Schillert, A.; Bickeböller, H.; Herrmann, T.; Trenkwalder, C.; Paulus, W.; Mansouri, A. The tumorigenicity of mouse embryonic stem cells and in vitro differentiated neuronal cells is controlled by the recipients' immune response. PLoS One 3:e2622; 2008.
12. Drukker, M.; Katchman, H.; Katz, G.; Even-Tov Friedman, S.; Shezen, E.; Hornstein, E.; Mandelboim, O.; Reisner, Y.; Benvenisty, N. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 24:221-229; 2006.
13. Durcova-Hills, G.; Wianny, F.; Merriman, J.; Zernicka-Goetz, M.; McLaren, A. Developmental fate of embryonic germ cells (EGCS), in vivo and in vitro. Differentiation 71:135-141; 2003.
14. Gertow, K.; Wolbank, S.; Rozell, B.; Sugars, R.; Andäng, M.; Parish, C. L.; Imreh, M. P.; Wendel, M.; Ahrlund-Richter, L. Organized development from human embryonic stem cells after injection into immunodeficient mice. Stem Cells Dev. 13:421-435; 2004.
15. Gore, A.; Li, Z.; Fung, H.; Young, J. E.; Agarwal, S.; Antosiewicz-Bourget, J.; Canto, I.; Giorgetti, A.; Israel, M. A.; Kiskinis, E.; Lee, J.; Loh, Y.; Manos, P. D.; Montserrat, N.; Panopoulos, A. D.; Ruiz, S.; Wilbert, M. L.; Yu, J.; Kirkness, E. F.; Izpisua Belmonte, J. C.; Rossi, D. J.; Thomson, J. A.; Eggan, K.; Daley, G. Q.; Goldstein, L. S. B.; Zhang, K. Somatic coding mutations in human induced pluripotent stem cells. Nature 471:63-67; 2011.
16. Grinnemo, K.; Genead, R.; Kumagai-Braesch, M.; Andersson, A.; Danielsson, C.; Månsson-Broberg, A.; Dellgren, G.; Strömberg, A.; Ekberg, H.; Hovatta, O.; Sylvén, C.; Corbascio, M. Costimulation blockade induces tolerance to HESC transplanted to the testis and induces regulatory T-cells to HESC transplanted into the heart. Stem Cells 26:1850-1857; 2008.
17. Han, D. W.; Tapia, N.; Joo, J. Y.; Greber, B.; Araúzo-Bravo, M. J.; Bernemann, C.; Ko, K.; Wu, G.; Stehling, M.; Do, J. T.; Schöler, H. R. Epiblast stem cell subpopulations represent mouse embryos of distinct pregastrulation stages. Cell 143:617-627; 2010.
18. Harkany, T.; Andäng, M.; Kingma, H. J.; Görcs, T. J.; Holmgren, C. D.; Zilberter, Y.; Ernfors, P. Region-specific generation of functional neurons from naive embryonic stem cells in adult brain. J. Neurochem. 88:1229-1239; 2004.
19. Hayashi, K.; Surani, M. A. Resetting the epigenome beyond pluripotency in the germline. Cell Stem Cell 4:493-498; 2009.
20. Hentze, H.; Soong, P. L.; Wang, S. T.; Phillips, B. W.; Putti, T. C.; Dunn, N. R. Teratoma formation by human embryonic stem cells: Evaluation of essential parameters for future safety studies. Stem Cell Res. 2:198-210; 2009.
21. Hovatta, O.; Jaconi, M.; Töhönen, V.; Béna, F.; Gimelli, S.; Bosman, A.; Holm, F.; Wyder, S.; Zdobnov, E. M.; Irion, O.; Andrews, P. W.; Antonarakis, S. E.; Zucchelli, M.; Kere, J.; Feki, A. A teratocarcinoma-like human embryonic stem cell (HESC) line and four HESC lines reveal potentially oncogenic genomic changes. PLoS One 5:e10263; 2010.
22. Jiang, W.; Bai, Z.; Zhang, D.; Shi, Y.; Yong, J.; Chen, S.; Ding, M.; Deng, H. Differentiation of mouse nuclear transfer embryonic stem cells into functional pancreatic β-cells. Diabetologia 51:1671-1679; 2008.
23. Kishi, Y.; Tanaka, Y.; Shibata, H.; Nakamura, S.; Takeuchi, K.; Masuda, S.; Ikeda, T.; Muramatsu, S.; Hanazono, Y. Variation in the incidence of teratomas after the transplantation of nonhuman primate ES cells into immunodeficient mice. Cell Transplant. 17:1095-1102; 2008.
24. Koch, C. A.; Geraldes, P.; Platt, J. L. Immunosuppression by embryonic stem cells. Stem Cells 26:89-98; 2008.
25. Kooreman, N. G.; Wu, J. C. Tumorigenicity of pluripotent stem cells: Biological insights from molecular imaging. J. R. Soc. Interface 7(Suppl 6):S753-S763; 2010.
26. Laflamme, M. A.; Chen, K. Y.; Naumova, A. V.; Muskheli, V.; Fugate, J. A.; Dupras, S. K.; Reinecke, H.; Xu, C.; Hassanipour, M.; Police, S.; O'Sullivan, C.; Collins, L.; Chen, Y.; Minami, E.; Gill, E. A.; Ueno, S.; Yuan, C.; Gold, J.; Murry, C. E. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 25:1015-1024; 2007.
27. Laurent, L. C.; Ulitsky, I.; Slavin, I.; Tran, H.; Schork, A.; Morey, R.; Lynch, C.; Harness, J. V.; Lee, S.; Barrero, M. J.; Ku, S.; Martynova, M.; Semechkin, R.; Galat, V.; Gottesfeld, J.; Izpisua Belmonte, J. C.; Murry, C.; Keirstead, H. S.; Park, H.; Schmidt, U.; Laslett, A. L.; Muller, F.; Nievergelt, C. M.; Shamir, R.; Loring, J. F. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCS and iPSCS during reprogramming and time in culture. Cell Stem Cell 8:106-118; 2011.
28. Lawrenz, B.; Schiller, H.; Willbold, E.; Ruediger, M.; Muhs, A.; Esser, S. Highly sensitive biosafety model for stem-cell-derived grafts. Cytotherapy 6:212-222; 2004.
29. Lee, A. S.; Tang, C.; Cao, F.; Xie, X.; van der Bogt, K.; Hwang, A.; Connolly, A. J.; Robbins, R. C.; Wu, J. C. Effects of cell number on teratoma formation by human embryonic stem cells. Cell Cycle 8:2608-2612; 2009.
30. Lifantseva, N.; Koltsova, A.; Krylova, T.; Yakovleva, T.; Poljanskaya, G.; Gordeeva, O. Expression patterns of cancer-testis antigens in human embryonic stem cells and their cell derivatives indicate lineage tracks. Stem Cells Int. 2011:795239; 2011.
31. Magliocca, J. F.; Held, I. K. A.; Odorico, J. S. Undifferentiated murine embryonic stem cells cannot induce portal tolerance but may possess immune privilege secondary to reduced major histocompatibility complex antigen expression. Stem Cells Dev. 15:707-717; 2006.
32. Maherali, N.; Sridharan, R.; Xie, W.; Utikal, J.; Eminli, S.; Arnold, K.; Stadtfeld, M.; Yachechko, R.; Tchieu, J.; Jaenisch, R.; Plath, K.; Hochedlinger, K. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1:55-70; 2007.
33. Mayshar, Y.; Ben-David, U.; Lavon, N.; Biancotti, J.; Yakir, B.; Clark, A. T.; Plath, K.; Lowry, W. E.; Benvenisty, N. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 7:521-531; 2010.
34. McLaren, A.; Durcova-Hills, G. Germ cells and pluripotent stem cells in the mouse. Reprod. Fertil. Dev. 13:661-664; 2001.
35. Nichols, J.; Smith, A. Naive and primed pluripotent states. Cell Stem Cell 4:487-492; 2009.
36. Nussbaum, J.; Minami, E.; Laflamme, M. A.; Virag, J. A. I.; Ware, C. B.; Masino, A.; Muskheli, V.; Pabon, L.; Reinecke, H.; Murry, C. E. Transplantation of undifferentiated murine embryonic stem cells in the heart: Teratoma formation and immune response. FASEB J. 21:1345-1357; 2007.
37. Prokhorova, T. A.; Harkness, L. M.; Frandsen, U.; Ditzel, N.; Schrøder, H. D.; Burns, J. S.; Kassem, M. Teratoma formation by human embryonic stem cells is site dependent and enhanced by the presence of Matrigel. Stem Cells Dev. 18:47-54; 2009.
38. Robertson, N. J.; Brook, F. A.; Gardner, R. L.; Cobbold, S. P.; Waldmann, H.; Fairchild, P. J. Embryonic stem cellderived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance. Proc. Natl. Acad. Sci. USA 104:20920-20925; 2007.
39. Sasaki, K.; Nagao, Y.; Kitano, Y.; Hasegawa, H.; Shibata, H.; Takatoku, M.; Hayashi, S.; Ozawa, K.; Hanazono, Y. Hematopoietic microchimerism in sheep after in utero transplantation of cultured cynomolgus embryonic stem cells. Transplantation 79:32-37; 2005.
40. Shibata, H.; Ageyama, N.; Tanaka, Y.; Kishi, Y.; Sasaki, K.; Nakamura, S.; Muramatsu, S.; Hayashi, S.; Kitano, Y.; Terao, K.; Hanazono, Y. Improved safety of hematopoietic transplantation with monkey embryonic stem cells in the allogeneic setting. Stem Cells 24:1450-1457; 2006.
41. Shih, C.; Forman, S. J.; Chu, P.; Slovak, M. Human embryonic stem cells are prone to generate primitive, undifferentiated tumors in engrafted human fetal tissues in severe combined immunodeficient mice. Stem Cells Dev. 16:893-902; 2007.
42. Stevens, L. C. Experimental production of testicular teratomas in mice. Proc. Natl. Acad. Sci. USA 52:654-661; 1964.
43. Sundberg, M.; Andersson, P.; Åkesson, E.; Odeberg, J.; Holmberg, L.; Inzunza, J.; Falci, S.; Öhman, J.; Suuronen, R.; Skottman, H.; Lehtimäki, K.; Hovatta, O.; Narkilahti, S.; Sundström, E. Markers of pluripotency and differentiation in human neural precursor cells derived from embryonic stem cells and CNS tissue. Cell Transplant. 20:177-191; 2011.
44. Swijnenburg, R.; Schrepfer, S.; Govaert, J. A.; Cao, F.; Ransohoff, K.; Sheikh, A. Y.; Haddad, M.; Connolly, A. J.; Davis, M. M.; Robbins, R. C.; Wu, J. C. Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc. Natl. Acad. Sci. USA 105:12991-12996; 2008.
45. Tanaka, Y.; Nakamura, S.; Shibata, H.; Kishi, Y.; Ikeda, T.; Masuda, S.; Sasaki, K.; Abe, T.; Hayashi, S.; Kitano, Y.; Nagao, Y.; Hanazono, Y. Sustained macroscopic engraftment of cynomolgus embryonic stem cells in xenogeneic large animals after in utero transplantation. Stem Cells Dev. 17:367-381; 2008.
46. Tang, C.; Lee, A. S.; Volkmer, J.; Sahoo, D.; Nag, D.; Mosley, A. R.; Inlay, M. A.; Ardehali, R.; Chavez, S. L.; Pera, R. R.; Behr, B.; Wu, J. C.; Weissman, I. L.; Drukker, M. An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells. Nat. Biotechnol. 29:829-834; 2011.
47. Urbach, A.; Benvenisty, N. Studying early lethality of 45, XO (Turner's syndrome) embryos using human embryonic stem cells. PLoS One 4:e4175; 2009.
48. Van Laake, L. W.; Passier, R.; Monshouwer-Kloots, J.; Verkleij, A. J.; Lips, D. J.; Freund, C.; den Ouden, K.; Ward-van Oostwaard, D.; Korving, J.; Tertoolen, L. G.; van Echteld, C. J.; Doevendans, P. A.; Mummery, C. L. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res. 1:9-24; 2007.
49. Werbowetski-Ogilvie, T. E.; Bossé, M.; Stewart, M.; Schnerch, A.; Ramos-Mejia, V.; Rouleau, A.; Wynder, T.; Smith, M.; Dingwall, S.; Carter, T.; Williams, C.; Harris, C.; Dolling, J.; Wynder, C.; Boreham, D.; Bhatia, M. Characterization of human embryonic stem cells with features of neoplastic progression. Nat. Biotechnol. 27:91-97; 2009.
50. Wernig, M.; Zhao, J.; Pruszak, J.; Hedlund, E.; Fu, D.; Soldner, F.; Broccoli, V.; Constantine-Paton, M.; Isacson, O.; Jaenisch, R. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl. Acad. Sci. USA 105:5856-5861; 2008.
51. Yachimovich-Cohen, N.; Even-Ram, S.; Shufaro, Y.; Rachmilewitz, J.; Reubinoff, B. Human embryonic stem cells suppress T cell responses via arginase I-dependent mechanism. J. Immunol. 184:1300-1308; 2010.
52. Yamashita, T.; Kawai, H.; Tian, F.; Ohta, Y.; Abe, K. Tumorigenic development of induced pluripotent stem cells in ischemic mouse brain. Cell Transplant. 20:883-891; 2011.
53. Zhang, S. C.; Wernig, M.; Duncan, I. D.; Brüstle, O.; Thomson, J. A. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat. Biotechnol. 19:1129-1133; 2001.